Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters
Year: 2016
Type: article
Study design: Observational Study
Source: Bone Marrow Transplantation
DOI: 10.1038/bmt.2016.139
Institutions: Leiden University Medical Center, Willem-Alexander Kinderziekenhuis, St Anna Children's Hospital, Medical University of Vienna, Policlinico San Matteo Fondazione, Hôpital Saint-Antoine, European Society for Blood and Marrow Transplantation, Aix-Marseille Université, Hôpital de la Timone, University of Helsinki, Karolinska University Hospital, Karolinska Institutet, King Faisal Specialist Hospital & Research Centre, Istituto Giannina Gaslini, University Hospital in Motol, University Medical Center Utrecht, Wilhelmina Children's Hospital, Sheffield Children's NHS Foundation Trust, Sheffield Children's Hospital, Hôpital Civil, Strasbourg, Royal Hospital for Children, Great Ormond Street Hospital, Great Ormond Street Hospital for Children NHS Foundation Trust, Hospital Infantil Universitario Niño Jesús, Children's Hospital at Westmead, Royal Victoria Infirmary, Great North Children's Hospital, Sydney Children's Hospital, Hammersmith Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: late effects, allogeneic hematopoietic stem cell transplantation, pediatric patients, total body irradiation, conditioning regimen, graft-versus-host disease, endocrine late effects, thyroid dysfunction, growth disorders, delayed puberty, central nervous system complications, secondary malignancies, risk factors
Open Access status: green
OpenAlex ID: W2474499649
